Breast Cancer Res. 2008;10(5):214. Epub 2008 Oct 31.

Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer.

Swanton C, Szallasi Z, Brenton JD, Downward J.

Source

Translational Cancer Therapeutics Laboratory, Cancer Research UK London Research Institute, London, UK. charles.swanton@cancer.org.uk

Abstract

The widespread introduction of high throughput RNA interference screening technology has revealed tumour drug sensitivity pathways to common cytotoxics such as paclitaxel, doxorubicin and 5-fluorouracil, targeted agents such as trastuzumab and inhibitors of AKT and Poly(ADP-ribose) polymerase (PARP) as well as endocrine therapies such as tamoxifen. Given the limited power of microarray signatures to predict therapeutic response in associative studies of small clinical trial cohorts, the use of functional genomic data combined with expression or sequence analysis of genes and microRNAs implicated in drug response in human tumours may provide a more robust method to guide adjuvant treatment strategies in breast cancer that are transferable across different expression platforms and patient cohorts.

PMID:: 18986507; [PubMed - indexed for MEDLINE]
PMCID:: PMC2614525

Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

Cancer Research UK/United Kingdom

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

New England Research Institutes Inc.

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer. [Breast Cancer Res. 2009]
An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
Bild AH, Parker JS, Gustafson AM, Acharya CR, Hoadley KA, Anders C, Marcom PK, Carey LA, Potti A, Nevins JR, et al. Breast Cancer Res. 2009; 11(4):R55. Epub 2009 Jul 28.
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. [Breast Cancer Res. 2010]
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.
Bauer JA, Ye F, Marshall CB, Lehmann BD, Pendleton CS, Shyr Y, Arteaga CL, Pietenpol JA. Breast Cancer Res. 2010; 12(3):R41. Epub 2010 Jun 24.
cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. [Breast Cancer Res Treat. 2006]
cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM. Breast Cancer Res Treat. 2006 Mar; 96(1):17-39. Epub 2005 Dec 2.
Review Gene-expression assays: new tools to individualize treatment of early-stage breast cancer. [Am J Health Syst Pharm. 2008]
Review Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.
Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM. Am J Health Syst Pharm. 2008 Jan 1; 65(1):23-8.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Med Biol. 2007]
Review Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Adv Exp Med Biol. 2007; 608:1-22.

See reviews... See all...

Cited by 3 PubMed Central articles

Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets. [Genome Med. 2010]
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets.
Swanton C, Larkin JM, Gerlinger M, Eklund AC, Howell M, Stamp G, Downward J, Gore M, Futreal PA, Escudier B, et al. Genome Med. 2010 Aug 11; 2(8):53. Epub 2010 Aug 11.
Review Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy. [Int J Hyperthermia. 2010]
Review Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy.
Dewhirst MW, Thrall DE, Palmer G, Schroeder T, Vujaskovic Z, Cecil Charles H, Macfall J, Wong T. Int J Hyperthermia. 2010; 26(3):283-93.
Review Molecular classification of solid tumours: towards pathway-driven therapeutics. [Br J Cancer. 2009]
Review Molecular classification of solid tumours: towards pathway-driven therapeutics.
Swanton C, Caldas C. Br J Cancer. 2009 May 19; 100(10):1517-22. Epub 2009 Apr 14.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Functional genomic analysis of drug sensitivity pathways to guide adjuvant strat...
Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer.
Breast Cancer Res. 2008 ;10(5):214. Epub 2008 Oct 31 .

PubMed
The Human Ageing Genomic Resources: online databases and tools for biogerontolog...
The Human Ageing Genomic Resources: online databases and tools for biogerontologists.
Aging Cell. 2009 Feb ;8(1):65-72. Epub 2008 Nov 5 .

PubMed
Biological markers to determine eligibility in trials for community-acquired pne...
Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.
Clin Infect Dis. 2008 Dec 1 ;47 Suppl 3:S127-32.

PubMed
Network hubs buffer environmental variation in Saccharomyces cerevisiae.
Network hubs buffer environmental variation in Saccharomyces cerevisiae.
PLoS Biol. 2008 Nov 4 ;6(11):e264.

PubMed
Assessing the role of polarization in docking.
Assessing the role of polarization in docking.
J Phys Chem A. 2008 Nov 27 ;112(47):12157-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: